Senior researcher in cancer epidemiology, specialist in Preventive Medicine and Public Health, with a well-established track record in population-based research, cancer registries, and studies on survival, incidence, and inequalities in solid and hematological cancers. PhD in Public Health from the Universitat Autònoma de Barcelona (UAB). I conduct my research activity at the Girona Cancer Registry and Epidemiology Unit (ICO-IdIBGi) and at the University of Girona, where I am an Associate Professor.
I have led and consolidated research lines based on high-quality population data, with a particular focus on hematological malignancies, childhood and adolescent cancer, and international comparative studies of survival and patterns of care. I am principal investigator of nationally competitive projects (ISCIII, AECC) and a key researcher in major European and international consortia (EUROCARE, CONCORD, VENUSCANCER, BENCHISTA, HAEMACARE), where I have held roles in methodological coordination and responsibility for population-based cancer registries.
My scientific output includes more than 200 articles in indexed international journals, with authorship in high-impact, first-quartile journals (The Lancet, Lancet Oncology, JNCI, Leukemia, Blood Advances, European Journal of Cancer, International Journal of Cancer), and substantial contributions to large-scale collaborative studies. I have consistently contributed to knowledge translation into public health through reports, guidelines, and advisory work for health authorities.
I currently lead the cancer epidemiology research group at IdIBGi, am a member of the REDECAN steering committee, and actively participate in national and European competitive research networks, contributing to the evaluation and improvement of cancer information systems and to the real-world impact of research on health policy.
Ten most relevant scientific contributions:
- Decisive contribution to the development and consolidation of population-based cancer registries as a key tool for epidemiological surveillance, health outcomes evaluation, and health care planning.
- Leadership in population-based survival studies of solid and hematological cancers, with significant contributions to landmark international projects such as EUROCARE and CONCORD.
- Substantial advances in the understanding of survival and prognosis of hematological malignancies using population-based data, helping to reduce the gap between clinical trial outcomes and real-world population results.
- Development of pioneering studies on childhood and adolescent cancer, with a particular focus on survival inequalities and patterns of care.
- Analysis of socioeconomic, geographic, and health care–related inequalities in cancer incidence and survival, with direct impact on the public health agenda.
- Methodological coordination and key contributions to European and international consortia (HAEMACARE, BENCHISTA, VENUSCANCER), particularly in standardization, data quality, and international comparability.
- Sustained high-impact scientific output, with more than 200 publications in indexed international journals, including first-quartile and top-impact journals.
- Contribution to the improvement of cancer information systems through the evaluation of the quality, completeness, and usefulness of population-based registries.
- Effective translation of scientific knowledge into public health practice through reports, guidelines, and technical advice to health authorities and planning bodies.
- Scientific leadership and training of researchers in cancer epidemiology, consolidating a competitive research group with strong national and international projection.